A study analysing post-transplant use of GLE/PIB in relation to sustained virologic response (SVR) based on route of administration
Latest Information Update: 22 May 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary) ; Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 22 May 2020 New trial record
- 25 Apr 2020 Results presented at the 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation